Literature DB >> 2440995

Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination.

S Komoly, M D Jeyasingham, O E Pratt, P L Lantos.   

Abstract

Both immunohistochemical and biochemical evidence is presented to show for the first time that carbonic anhydrase II (CA II) activity falls in the brain of mice in cuprizone (bis(cyclohexanone)oxalyldihydrazone) induced demyelination well before demyelination develops. This fall began during the first week, whereas the first signs of myelin degeneration induced by cuprizone did not appear until 3 weeks and demyelination in the superior cerebellar peduncle in the mouse took 6-8 weeks to develop. The findings suggest that oligodendrocyte CA II activity is essential either for the survival of oligodendrocytes or for the maintenance of central myelin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440995     DOI: 10.1016/0022-510x(87)90268-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Cuprizone Administration Alters the Iron Metabolism in the Mouse Model of Multiple Sclerosis.

Authors:  E Varga; E Pandur; H Abrahám; A Horváth; P Ács; S Komoly; A Miseta; K Sipos
Journal:  Cell Mol Neurobiol       Date:  2018-02-20       Impact factor: 5.046

2.  Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.

Authors:  Michal Wegrzynowicz; Hunter K Holt; David B Friedman; Aaron B Bowman
Journal:  J Proteome Res       Date:  2012-01-20       Impact factor: 4.466

Review 3.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

4.  mTOR Signaling Regulates Metabolic Function in Oligodendrocyte Precursor Cells and Promotes Efficient Brain Remyelination in the Cuprizone Model.

Authors:  Marisa A Jeffries; Lauren E McLane; Luipa Khandker; Marie L Mather; Angelina V Evangelou; Divyangi Kantak; Jennifer N Bourne; Wendy B Macklin; Teresa L Wood
Journal:  J Neurosci       Date:  2021-08-20       Impact factor: 6.709

5.  Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

Authors:  S Komoly; L D Hudson; H D Webster; C A Bondy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

6.  Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes.

Authors:  Karelle Bénardais; Alexandra Kotsiari; Jelena Skuljec; Paraskevi N Koutsoudaki; Viktoria Gudi; Vikramjeet Singh; Franca Vulinović; Thomas Skripuletz; Martin Stangel
Journal:  Neurotox Res       Date:  2013-02-08       Impact factor: 3.911

7.  Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.

Authors:  Diara A Santiago González; Veronica T Cheli; Norma N Zamora; Tenzing N Lama; Vilma Spreuer; Geoffrey G Murphy; Pablo M Paez
Journal:  J Neurosci       Date:  2017-09-12       Impact factor: 6.167

8.  Multiple restricted origin of oligodendrocytes.

Authors:  N Spassky; C Goujet-Zalc; E Parmantier; C Olivier; S Martinez; A Ivanova; K Ikenaka; W Macklin; I Cerruti; B Zalc; J L Thomas
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

9.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

10.  Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes.

Authors:  Johannes Goldberg; Moritz Daniel; Yasemin van Heuvel; Marion Victor; Cordian Beyer; Tim Clarner; Markus Kipp
Journal:  Cell Mol Neurobiol       Date:  2013-08-25       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.